These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2863777)

  • 21. Zuclopenthixol decanoate in the management of behavioural disorders in mentally handicapped patients.
    Izmeth MG; Khan SY; Kumarajeewa DI; Shivanathan S; Veall RM; Wiley YV
    Pharmatherapeutica; 1988; 5(4):217-27. PubMed ID: 2902642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials.
    Frye MA; Eudicone J; Pikalov A; McQuade RD; Marcus RN; Carlson BX
    J Clin Psychopharmacol; 2008 Apr; 28(2):243-5. PubMed ID: 18344741
    [No Abstract]   [Full Text] [Related]  

  • 23. A double-blind placebo-controlled discontinuation study of zuclopenthixol for the treatment of aggressive disruptive behaviours in adults with mental retardation - secondary parameter analyses.
    Hässler F; Glaser T; Pap AF; Beneke M; Diefenbacher A; Reis O;
    Pharmacopsychiatry; 2008 Nov; 41(6):232-9. PubMed ID: 19067260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experiments with the new oral long-acting neuroleptic clopimozide (R 29 764).
    Floru L; Tegeler J
    Arzneimittelforschung; 1978; 28(2):341-4. PubMed ID: 25071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study using double-blind method of sultopride and thioproperazine].
    Sizaret P; Moreau C
    Encephale; 1977; 3(2):111-20. PubMed ID: 19230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder.
    Connor DF; McLaughlin TJ; Jeffers-Terry M
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):140-56. PubMed ID: 18439112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Allen MH; Feifel D; Lesem MD; Zimbroff DL; Ross R; Munzar P; Spyker DA; Cassella JV
    J Clin Psychiatry; 2011 Oct; 72(10):1313-21. PubMed ID: 21294997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of the need for anticholinergic medication in patients treated with long-term antipsychotics.
    Caradoc-Davies G; Menkes DB; Clarkson HO; Mullen PE
    Aust N Z J Psychiatry; 1986 Jun; 20(2):225-32. PubMed ID: 2876700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial.
    Van Bellinghen M; De Troch C
    J Child Adolesc Psychopharmacol; 2001; 11(1):5-13. PubMed ID: 11322745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L; Meng X; Hochfeld M; Stahl SM
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer disease.
    Rosenheck RA; Leslie DL; Sindelar JL; Miller EA; Tariot PN; Dagerman KS; Davis SM; Lebowitz BD; Rabins P; Hsiao JK; Lieberman JA; Schneider LS;
    Arch Gen Psychiatry; 2007 Nov; 64(11):1259-68. PubMed ID: 17984395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effectiveness of intramuscular biperiden in acute akathisia: a double-blind, randomized, placebo-controlled study.
    Baskak B; Atbasoglu EC; Ozguven HD; Saka MC; Gogus AK
    J Clin Psychopharmacol; 2007 Jun; 27(3):289-94. PubMed ID: 17502777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of quetiapine on aggression and hostility in patients with schizophrenia.
    Arango C; Bernardo M
    Hum Psychopharmacol; 2005 Jun; 20(4):237-41. PubMed ID: 15830402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
    Poyurovsky M; Pashinian A; Weizman R; Fuchs C; Weizman A
    Biol Psychiatry; 2006 Jun; 59(11):1071-7. PubMed ID: 16497273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease.
    Streim JE; Porsteinsson AP; Breder CD; Swanink R; Marcus R; McQuade R; Carson WH
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):537-50. PubMed ID: 18591574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.
    Tariot PN; Schneider L; Katz IR; Mintzer JE; Street J; Copenhaver M; Williams-Hughes C
    Am J Geriatr Psychiatry; 2006 Sep; 14(9):767-76. PubMed ID: 16905684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.
    Pae CU; Lim HK; Peindl K; Ajwani N; Serretti A; Patkar AA; Lee C
    Int Clin Psychopharmacol; 2008 Jan; 23(1):1-8. PubMed ID: 18090502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trial.
    Strous RD; Stryjer R; Maayan R; Gal G; Viglin D; Katz E; Eisner D; Weizman A
    Psychoneuroendocrinology; 2007 Feb; 32(2):96-105. PubMed ID: 17208382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.